JP Morgan Chase
ALNA

JP Morgan Chase’s Allena Pharmaceuticals ALNA Stock Holding History

JP Morgan Chase’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11
Closed – – 6070
2020
Q3 		$0 Buy
+11
New +$15 ﹤0.01% 5920
2019
Q4 		– Sell
-56,579
Closed -$223K – 5979
2019
Q3 		$223K Buy
56,579
+9,678
+21% +$41.5K ﹤0.01% 4589
2019
Q2 		$195K Sell
46,901
-172,160
-79% -$941K ﹤0.01% 4681
2019
Q1 		$1.54M Sell
219,061
-14,999
-6% -$109K ﹤0.01% 3519
2018
Q4 		$1.27M Sell
234,060
-1,265
-0.5% -$10.9K ﹤0.01% 3585
2018
Q3 		$2.53M Sell
235,325
-3,885
-2% -$42.7K ﹤0.01% 3299
2018
Q2 		$3.12M Buy
239,210
+43,439
+22% +$626K ﹤0.01% 3059
2018
Q1 		$2.16M Sell
195,771
-162,072
-45% -$1.35M ﹤0.01% 3217
2017
Q4 		$3.6M Buy
+357,843
New +$4.41M ﹤0.01% 2940

Other funds holding ALNA

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

JP Morgan Chase's ALNA Position: Q4 2020 in Review

JP Morgan Chase sold out of Allena Pharmaceuticals (ALNA) in Q4 2020, closing a stake of 11 shares.

JP Morgan Chase first reported a position in ALNA in Q4 2017 and held it in 9 quarters. The position peaked at $3.6M in Q4 2017. 28 funds tracked by Wall St. Rank hold ALNA as of Q4 2020.

  • JP Morgan Chase reported no remaining Allena Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 11 Allena Pharmaceuticals shares in Q4 2020.
  • JP Morgan Chase first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 9 quarters.
  • JP Morgan Chase's Allena Pharmaceuticals position peaked at $3.6M in Q4 2017.
  • 28 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.